<DOC>
	<DOC>NCT00000226</DOC>
	<brief_summary>The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects under open dosing conditions.</brief_summary>
	<brief_title>Alternate-Day Buprenorphine Administration. Phase VII - 8</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>July 1996</verification_date>
</DOC>